These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16177111)

  • 1. Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence.
    Skinner JA; Pilione MR; Shen H; Harvill ET; Yuk MH
    J Immunol; 2005 Oct; 175(7):4647-52. PubMed ID: 16177111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.
    Pilione MR; Harvill ET
    Infect Immun; 2006 Feb; 74(2):1043-9. PubMed ID: 16428751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella type III secretion and adenylate cyclase toxin synergize to drive dendritic cells into a semimature state.
    Skinner JA; Reissinger A; Shen H; Yuk MH
    J Immunol; 2004 Aug; 173(3):1934-40. PubMed ID: 15265927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response.
    Siciliano NA; Skinner JA; Yuk MH
    J Immunol; 2006 Nov; 177(10):7131-8. PubMed ID: 17082630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.
    Pilione MR; Pishko EJ; Preston A; Maskell DJ; Harvill ET
    Infect Immun; 2004 May; 72(5):2837-42. PubMed ID: 15102794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.
    Yuk MH; Harvill ET; Cotter PA; Miller JF
    Mol Microbiol; 2000 Mar; 35(5):991-1004. PubMed ID: 10712682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative roles for fimbria and filamentous hemagglutinin in Bordetella adherence and immune modulation.
    Scheller EV; Melvin JA; Sheets AJ; Cotter PA
    mBio; 2015 May; 6(3):e00500-15. PubMed ID: 26015497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection.
    Pilione MR; Agosto LM; Kennett MJ; Harvill ET
    Cell Microbiol; 2006 May; 8(5):758-68. PubMed ID: 16611225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative role of immunoglobulin A in protective immunity against the Bordetellae.
    Wolfe DN; Kirimanjeswara GS; Goebel EM; Harvill ET
    Infect Immun; 2007 Sep; 75(9):4416-22. PubMed ID: 17591791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine.
    Nicholson TL; Brockmeier SL; Loving CL; Register KB; Kehrli ME; Shore SM
    Infect Immun; 2014 Mar; 82(3):1092-103. PubMed ID: 24366249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type Six Secretion System of Bordetella bronchiseptica and Adaptive Immune Components Limit Intracellular Survival During Infection.
    Bendor L; Weyrich LS; Linz B; Rolin OY; Taylor DL; Goodfield LL; Smallridge WE; Kennett MJ; Harvill ET
    PLoS One; 2015; 10(10):e0140743. PubMed ID: 26485303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.
    Reissinger A; Skinner JA; Yuk MH
    Infect Immun; 2005 Jan; 73(1):308-16. PubMed ID: 15618167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.
    Mann P; Goebel E; Barbarich J; Pilione M; Kennett M; Harvill E
    Infect Immun; 2007 Jul; 75(7):3665-72. PubMed ID: 17452472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A deep rough type structure in Bordetella bronchiseptica lipopolysaccharide modulates host immune responses.
    Sisti F; Fernández J; Higgins SC; Casabuono A; Couto A; Mills KH; Hozbor D
    Microbiol Immunol; 2011 Dec; 55(12):847-54. PubMed ID: 22039958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of urease does not affect the ability of Bordetella bronchiseptica to colonise and persist in the murine respiratory tract.
    McMillan DJ; Medina E; Guzmán CA; Walker MJ
    FEMS Microbiol Lett; 1999 Sep; 178(1):7-11. PubMed ID: 10483716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity.
    Irie Y; Yuk MH
    FEMS Microbiol Lett; 2007 Oct; 275(2):191-8. PubMed ID: 17714485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory
    Jeron A; Boehme JD; Volckmar J; Gereke M; Yevsa T; Geffers R; Guzmán CA; Schreiber J; Stegemann-Koniszewski S; Bruder D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Bordetella O antigen in respiratory tract infection.
    Burns VC; Pishko EJ; Preston A; Maskell DJ; Harvill ET
    Infect Immun; 2003 Jan; 71(1):86-94. PubMed ID: 12496152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.
    Fennelly NK; Sisti F; Higgins SC; Ross PJ; van der Heide H; Mooi FR; Boyd A; Mills KH
    Infect Immun; 2008 Mar; 76(3):1257-66. PubMed ID: 18195025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.